Covista Inc.
NYSE:CVSA · New York Stock Exchange
-$1.68 today
Vol 0.18M · Avg 0.32M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
16.2%
avg 6.4%
ROIC
11.7%
avg 7.1%
ROA
8.5%
avg 3.8%
Analysis
ROE is currently the strongest return metric at 16.2% versus its period average of 6.4%. 3 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Stephen W. Beard | CEO & Chairman | $3.25M | — | 55 | $424,033.00 | 1.25% |
Michael Betz | Chief Growth & Innovation Officer and President of Walden University | $1.91M | — | 52 | $25,395.00 | 0.07% |
Douglas G. Beck | Senior VP of Institutional Support Services, General Counsel & Corporate Secretary | $1.12M | — | 59 | $38,159.00 | 0.11% |
Robert J. Phelan | Senior VP & CFO | $1.07M | — | 60 | $55,806.00 | 0.16% |
Scott Day Liles | President of Adtalem Medical & Veterinary | $948,518.00 | — | 59 | $13,103.00 | 0.04% |
Karen Sue Cox | President of Chamberlain University | $727,172.00 | — | 65 | $31,596.00 | 0.09% |
Amelia Manning | President of Chamberlain University | $727,172.00 | — | — | $0.00 | <0.01% |
Jeremy Cohen | Vice President of Investor Relations | — | — | — | — | — |
Manjunath Gangadharan | VP & Chief Accounting Officer | — | — | 42 | $5,271.00 | 0.02% |
Megan Noel | Senior VP & Chief Corporate Affairs Officer | — | — | 40 | — | — |
Sara Hill | Senior VP & Chief Human Resources Officer | — | — | 56 | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
4
$3.75M
Sells
6
$5.51M
Net Sentiment
$1.75M
Net selling
Most Active
MALAFRONTE MICHAEL W
4 transactions
Analysis
Insiders reported 4 buys worth $3.75M and 6 sells worth $5.51M over the last 12 months. That adds up to net selling of $1.75M. MALAFRONTE MICHAEL W was the most active insider with 4 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | -0.5% | +12.7% (14yr)1 analysts |
| Revenue | N/A | N/A | -3.0% | +1.7% (14yr)1 analysts |
| Net Income | N/A | N/A | -0.4% | +8.2% (14yr)1 analysts |
| EBIT | N/A | N/A | -13.0% | +3.5% (14yr)1 analysts |
Analysis
Recent growth has been strongest in Net Income at -0.4% over three years. Forward estimates point to EPS at +12.7% (14yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
No competitor data available.
Who manages CVSA?
Covista Inc. (CVSA) lists 11 active executives. The top listed executive is Douglas G. Beck, Senior VP of Institutional Support Services, General Counsel & Corporate Secretary.
Are CVSA insiders buying or selling?
Recent insider activity shows net selling of $1.86M.
Explore More
Continue the stock analysis
Jump to another research area for this company.